February 7, 2013—The Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA) issued two 340B program policy releases this morning regarding (1) the prohibition against obtaining “covered outpatient drugs” through a group purchasing organization (GPO) for disproportionate share (DSH), children’s, and free-standing cancer hospitals and (2) the use of OPA’s Medicaid exclusion file for avoiding duplicate discounts.
The Monitor will report on this development in greater depth in the coming days.